Skip to main content

Quest PharmaTech: Top 10 Undervalued Biotechnology Industry Stocks (QPT)

AI-generated - The Globe and Mail - Sun Jul 7, 2024

Quest PharmaTech is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Biotechnology: Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drugrelated technologies.

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
XRTXXORTX Therapeutics2.465.773.31 (134.5%)11856.00.00.0
CYTOCytophage Technologies0.340.620.27 (79.0%)2433917.20.00.0
QPTQuest PharmaTech0.030.050.02 (76.8%)10525.10.00.0
HEMHemostemix0.050.090.04 (76.0%)744484.10.00.0
MRVLMarvel Biosciences0.120.180.06 (53.0%)271864.80.00.0
THTheratechnologies1.872.690.82 (43.9%)1668492.30.00.0
RVXResverlogix0.060.080.02 (36.8%)3390124.40.00.0
MBXMicrobix Biosystems0.300.400.09 (29.8%)5519342.40.010.3
VXLVaxil Bio0.010.010.00 (27.7%)1.40.00.0
AEZSAEterna Zentaris6.207.601.40 (22.5%)239611.50.00.0

All data provided as of July 08, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Quest PharmaTech

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Quest PharmaTech is listed under QPT on the TSX Venture Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.